Logo image of LTRX

LANTRONIX INC (LTRX) Stock Fundamental Analysis

USA - NASDAQ:LTRX - US5165482036 - Common Stock

5 USD
+0.01 (+0.2%)
Last: 10/8/2025, 8:00:00 PM
4.9532 USD
-0.05 (-0.94%)
After Hours: 10/8/2025, 8:00:00 PM
Fundamental Rating

4

Overall LTRX gets a fundamental rating of 4 out of 10. We evaluated LTRX against 48 industry peers in the Communications Equipment industry. While LTRX seems to be doing ok healthwise, there are quite some concerns on its profitability. LTRX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

LTRX had positive earnings in the past year.
In the past year LTRX had a positive cash flow from operations.
In the past 5 years LTRX always reported negative net income.
Of the past 5 years LTRX 4 years had a positive operating cash flow.
LTRX Yearly Net Income VS EBIT VS OCF VS FCFLTRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M

1.2 Ratios

The Return On Assets of LTRX (-9.19%) is worse than 72.92% of its industry peers.
LTRX has a worse Return On Equity (-15.29%) than 68.75% of its industry peers.
Industry RankSector Rank
ROA -9.19%
ROE -15.29%
ROIC N/A
ROA(3y)-6.15%
ROA(5y)-5.58%
ROE(3y)-10.81%
ROE(5y)-9.57%
ROIC(3y)N/A
ROIC(5y)N/A
LTRX Yearly ROA, ROE, ROICLTRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5 -10 -15 -20

1.3 Margins

LTRX has a Gross Margin of 42.06%. This is comparable to the rest of the industry: LTRX outperforms 56.25% of its industry peers.
LTRX's Gross Margin has been stable in the last couple of years.
LTRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.63%
GM growth 5Y-1.3%
LTRX Yearly Profit, Operating, Gross MarginsLTRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

5

2. Health

2.1 Basic Checks

LTRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LTRX has been increased compared to 1 year ago.
LTRX has more shares outstanding than it did 5 years ago.
LTRX has a better debt/assets ratio than last year.
LTRX Yearly Shares OutstandingLTRX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
LTRX Yearly Total Debt VS Total AssetsLTRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

LTRX has an Altman-Z score of 0.99. This is a bad value and indicates that LTRX is not financially healthy and even has some risk of bankruptcy.
LTRX has a Altman-Z score of 0.99. This is comparable to the rest of the industry: LTRX outperforms 45.83% of its industry peers.
The Debt to FCF ratio of LTRX is 1.73, which is an excellent value as it means it would take LTRX, only 1.73 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.73, LTRX is in the better half of the industry, outperforming 64.58% of the companies in the same industry.
A Debt/Equity ratio of 0.12 indicates that LTRX is not too dependend on debt financing.
The Debt to Equity ratio of LTRX (0.12) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.73
Altman-Z 0.99
ROIC/WACCN/A
WACC9.77%
LTRX Yearly LT Debt VS Equity VS FCFLTRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

LTRX has a Current Ratio of 2.54. This indicates that LTRX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of LTRX (2.54) is better than 68.75% of its industry peers.
LTRX has a Quick Ratio of 1.68. This is a normal value and indicates that LTRX is financially healthy and should not expect problems in meeting its short term obligations.
LTRX has a Quick ratio of 1.68. This is comparable to the rest of the industry: LTRX outperforms 58.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 1.68
LTRX Yearly Current Assets VS Current LiabilitesLTRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

6

3. Growth

3.1 Past

LTRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -65.85%.
LTRX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.24% yearly.
LTRX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.33%.
Measured over the past years, LTRX shows a quite strong growth in Revenue. The Revenue has been growing by 15.46% on average per year.
EPS 1Y (TTM)-65.85%
EPS 3Y-25.6%
EPS 5Y9.24%
EPS Q2Q%-93.33%
Revenue 1Y (TTM)-23.33%
Revenue growth 3Y-1.77%
Revenue growth 5Y15.46%
Sales Q2Q%-41.23%

3.2 Future

Based on estimates for the next years, LTRX will show a very strong growth in Earnings Per Share. The EPS will grow by 45.79% on average per year.
LTRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.65% yearly.
EPS Next Y43.89%
EPS Next 2Y49.72%
EPS Next 3Y58.83%
EPS Next 5Y45.79%
Revenue Next Year3.04%
Revenue Next 2Y7.38%
Revenue Next 3Y13.05%
Revenue Next 5Y11.65%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LTRX Yearly Revenue VS EstimatesLTRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M
LTRX Yearly EPS VS EstimatesLTRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 0.4 0.6

4

4. Valuation

4.1 Price/Earnings Ratio

LTRX is valuated quite expensively with a Price/Earnings ratio of 35.71.
LTRX's Price/Earnings ratio is in line with the industry average.
LTRX's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.91.
The Price/Forward Earnings ratio is 24.82, which indicates a rather expensive current valuation of LTRX.
Based on the Price/Forward Earnings ratio, LTRX is valued a bit cheaper than 60.42% of the companies in the same industry.
LTRX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.30.
Industry RankSector Rank
PE 35.71
Fwd PE 24.82
LTRX Price Earnings VS Forward Price EarningsLTRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of LTRX indicates a somewhat cheap valuation: LTRX is cheaper than 64.58% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 28.96
EV/EBITDA N/A
LTRX Per share dataLTRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LTRX's earnings are expected to grow with 58.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.81
PEG (5Y)3.87
EPS Next 2Y49.72%
EPS Next 3Y58.83%

0

5. Dividend

5.1 Amount

LTRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LANTRONIX INC

NASDAQ:LTRX (10/8/2025, 8:00:00 PM)

After market: 4.9532 -0.05 (-0.94%)

5

+0.01 (+0.2%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)08-27 2025-08-27/amc
Earnings (Next)11-05 2025-11-05
Inst Owners29.56%
Inst Owner Change0%
Ins Owners7.14%
Ins Owner Change2.93%
Market Cap196.35M
Analysts82
Price Target5.74 (14.8%)
Short Float %0.93%
Short Ratio0.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-11.76%
Min EPS beat(2)-21.57%
Max EPS beat(2)-1.96%
EPS beat(4)1
Avg EPS beat(4)-8.53%
Min EPS beat(4)-33.16%
Max EPS beat(4)22.55%
EPS beat(8)3
Avg EPS beat(8)16.38%
EPS beat(12)5
Avg EPS beat(12)17.42%
EPS beat(16)8
Avg EPS beat(16)15.34%
Revenue beat(2)0
Avg Revenue beat(2)-2.37%
Min Revenue beat(2)-4.03%
Max Revenue beat(2)-0.71%
Revenue beat(4)0
Avg Revenue beat(4)-3.34%
Min Revenue beat(4)-7.07%
Max Revenue beat(4)-0.71%
Revenue beat(8)2
Avg Revenue beat(8)-1.99%
Revenue beat(12)2
Avg Revenue beat(12)-2.58%
Revenue beat(16)6
Avg Revenue beat(16)0.04%
PT rev (1m)0%
PT rev (3m)9.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.09%
EPS NY rev (1m)1.28%
EPS NY rev (3m)1.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.23%
Revenue NY rev (1m)-0.59%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE 35.71
Fwd PE 24.82
P/S 1.6
P/FCF 28.96
P/OCF 26.95
P/B 2.64
P/tB 4.96
EV/EBITDA N/A
EPS(TTM)0.14
EY2.8%
EPS(NY)0.2
Fwd EY4.03%
FCF(TTM)0.17
FCFY3.45%
OCF(TTM)0.19
OCFY3.71%
SpS3.13
BVpS1.89
TBVpS1.01
PEG (NY)0.81
PEG (5Y)3.87
Profitability
Industry RankSector Rank
ROA -9.19%
ROE -15.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.06%
FCFM 5.52%
ROA(3y)-6.15%
ROA(5y)-5.58%
ROE(3y)-10.81%
ROE(5y)-9.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.63%
GM growth 5Y-1.3%
F-Score4
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.73
Debt/EBITDA N/A
Cap/Depr 8.37%
Cap/Sales 0.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.54
Quick Ratio 1.68
Altman-Z 0.99
F-Score4
WACC9.77%
ROIC/WACCN/A
Cap/Depr(3y)21.19%
Cap/Depr(5y)23.11%
Cap/Sales(3y)1.12%
Cap/Sales(5y)1.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.85%
EPS 3Y-25.6%
EPS 5Y9.24%
EPS Q2Q%-93.33%
EPS Next Y43.89%
EPS Next 2Y49.72%
EPS Next 3Y58.83%
EPS Next 5Y45.79%
Revenue 1Y (TTM)-23.33%
Revenue growth 3Y-1.77%
Revenue growth 5Y15.46%
Sales Q2Q%-41.23%
Revenue Next Year3.04%
Revenue Next 2Y7.38%
Revenue Next 3Y13.05%
Revenue Next 5Y11.65%
EBIT growth 1Y-396.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year65.64%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.88%
OCF growth 3YN/A
OCF growth 5YN/A